EFFECT OF DIETARY-PROTEIN ON STRIATAL DOPAMINE FORMATION FOLLOWING L-DOPA ADMINISTRATION - AN INVIVO STUDY

被引:16
|
作者
BRANNAN, T
MARTINEZTICA, J
YAHR, MD
机构
[1] Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, One Gustave L. Levy Place
关键词
L-DOPA; DOPAMINE; PARKINSONS DISEASE; CEREBRAL MICRODIALYSIS; DIET; PROTEIN;
D O I
10.1016/0028-3908(91)90143-Y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We varied the diet of rats and monitored extracellular levels of dopamine in the striatum. Following L-dopa administration, the increase in striatal dopamine levels was attenuated by 78% in rats that had consumed a high protein diet as opposed to a low protein diet. Similarly, the increase in striatal dopamine levels was attenuated by 61% in rats that had just eaten a protein-containig meal as compared to fasting animals. These findings demonstrate that dietary protein strongly affects brain dopamine formation from exogenous L-dopa.
引用
收藏
页码:1125 / 1127
页数:3
相关论文
共 50 条
  • [1] Effects of repeated administration of L-DOPA and apomorphine on circling behavior and striatal dopamine formation
    Brannan, T
    Prikhojan, A
    Yahr, MD
    BRAIN RESEARCH, 1998, 784 (1-2) : 148 - 153
  • [2] EFFECT OF REPEATED ELECTROCONVULSIVE SHOCK ON STRIATAL L-DOPA AND DOPAMINE METABOLISM - AN IN-VIVO STUDY
    BRANNAN, T
    MARTINEZTICA, J
    YAHR, MD
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1993, 6 (01) : 35 - 44
  • [3] Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation
    Kannari, K
    Tanaka, H
    Maeda, T
    Tomiyama, M
    Suda, T
    Matsunaga, M
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 (01) : 263 - 269
  • [4] STRIATAL L-DOPA METABOLISM STUDIED INVIVO IN RATS WITH NIGROSTRIATAL LESIONS
    BRANNAN, T
    BHARDWAJ, A
    MARTINEZTICA, J
    WEINBERGER, J
    YAHR, M
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1990, 2 (01) : 15 - 22
  • [5] Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons
    Cheng, NN
    Maeda, T
    Kume, T
    Kaneko, S
    Kochiyama, H
    Akaike, A
    Goshima, Y
    Misu, Y
    BRAIN RESEARCH, 1996, 743 (1-2) : 278 - 283
  • [6] Evaluation of rat striatal L-dopa and DA concentration after intraperitoneal administration of L-dopa prodrugs in liposomal formulations
    Di Stefano, A
    Carafa, M
    Sozio, P
    Pinnen, F
    Braghiroli, D
    Orlando, G
    Cannazza, G
    Ricciutelli, M
    Marianecci, C
    Santucci, E
    JOURNAL OF CONTROLLED RELEASE, 2004, 99 (02) : 293 - 300
  • [7] EFFECT OF A SELECTIVE MAO-A INHIBITOR (RO-41-1049) ON STRIATAL L-DOPA AND DOPAMINE METABOLISM - AN IN-VIVO STUDY
    BRANNAN, T
    PRIKHOJAN, A
    YAHR, MD
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1994, 8 (1-2) : 99 - 105
  • [8] Time-course and dose-response study on the effects of chronic L-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity
    Fornai, F
    Battaglia, G
    Gesi, M
    Giorgi, FS
    Orzi, F
    Nicoletti, F
    Ruggieri, S
    BRAIN RESEARCH, 2000, 887 (01) : 110 - 117
  • [9] An in vivo comparison of the capacity of striatal versus extrastriatal brain regions to form dopamine from exogenously administered L-dopa
    Brannan, T
    Prikhojan, A
    Yahr, MD
    JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (11) : 1287 - 1294
  • [10] Pharmacological treatment with L-DOPA may reduce striatal dopamine transporter binding in in vivo imaging studies
    Nikolaus, S.
    Antke, C.
    Hautzel, H.
    Mueller, H. -W.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2016, 55 (01): : 21 - 28